« Illumina Introduces High Throughput DNA Methylation Profiling | Home | Late Fall Issue of Journal of Epigenetics Available »
Results of Clinical Trial in Blood-Based Cancer Detection
By Trevor | January 11, 2007
BioCangen Inc. has announced the initial results of its clinical validation study of early cancer detection.
- Among the blood samples from 102 patients with solid tumors including lung cancer, colon cancer, breast cancer and stomach cancer, 73 samples were correctly identified as the cancer, showing a 71.6% detection sensitivity. Among the 82 health individuals, only 3 samples were identified as the cancer, indicating a 96.3% specificity.
These results will be further validated with multi-center trials for submission to the FDA. Link
Related Posts:
Topics: cancer, methylation, news links |
Comments are closed.
